Lactylation in cancer progression and drug resistance
Drug Resistance Updates · 2025-07 · 81 · 101248
DOI: 10.1016/j.drup.2025.101248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2025-07. Verfasst von Yuxiu Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Diseases 1, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer …. Hauptthemen laut MEDLINE: Neoplasms, Drug Resistance, Neoplasm, Lactic Acid. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 140 Literaturangaben.
Abstract (Originalsprache)
Lactate plays a crucial role as an energy substrate, metabolite, and signaling molecule in cancer. Lactate has long been considered a byproduct of glycolysis. Still, the lactate shuttle hypothesis has changed the lactate paradigm, revealing the implications of lactate in cellular metabolism and cellular communications that can transcend the compartment barrier and occur within and between different cells, tissues, and organs. Due to the Warburg effect, the tumor produces a large amount of lactate, thus creating a low-nutrition, hypoxic, and low-pH tumor microenvironment (TME). Consequently, immunosuppressive networks are built to acquire immune evasion potential and regulate tumor growth. Lactylation is a newly discovered post-translational modification of lysine residues with the capacity for transcriptional regulation via histone modification and modulation of non-histone protein functions, which links gene regulation to cellular metabolism by aberrant metabolism activity and epigenetic modification. There is growing evidence that lactylation plays a crucial role in cancer progression and drug resistance. Targeting lactylation enzymes or metabolic pathways has shown promising effects in suppressing cancer progression and drug resistance, highlighting the therapeutic potential of this modification. Therefore, in this review, we offer a systematic overview of lactate homeostasis in physiological and pathological processes as well as discuss the influence of lactylation in cancer progression and drug resistance and underlying molecular mechanisms, providing a theoretical basis for further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Digestive Diseases 1, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.
- Department of Breast Medicine 2, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.
- Laboratory Department, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.
- Department of Gynecology Surgery 4, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.
- Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.
- First Clinical College, Liaoning University of Traditional Chinese Medicine Affiliated Hospital, Liaoning Provincial Traditional Chinese Medicine Hospital, Liaoning University of Traditional Chinese Medicine, Shenyang,…
Zitieren
APA
Sun, Y., Wang, H., Cui, Z., Yu, T., Song, Y., Gao, H., Tang, R., Wang, X., Li, B., Li, W., & Wang, Z. (2025). Lactylation in cancer progression and drug resistance. Drug Resistance Updates, 81, 101248. https://doi.org/10.1016/j.drup.2025.101248
Vancouver
Sun Y, Wang H, Cui Z, Yu T, Song Y, Gao H, et al. Lactylation in cancer progression and drug resistance. Drug Resistance Updates. 2025;81:101248. doi:10.1016/j.drup.2025.101248
BibTeX
@article{Sun2025,
author = {Sun, Yuxiu and Wang, He and Cui, Zhe and Yu, Tingting and Song, Yuanming and Gao, Haolai and Tang, Ruihong and Wang, Xinlei and Li, Binru and Li, Wenxin and Wang, Zhe},
title = {Lactylation in cancer progression and drug resistance},
journal = {Drug Resistance Updates},
year = {2025},
volume = {81},
pages = {101248},
doi = {10.1016/j.drup.2025.101248}
}
EUVIMED